PI
Prof. Reinhard Dummer
Melanom – 2nd line
Stadium III oder IV
(Auch mukosales oder Aderhaut-melanom)
TYRP1-Targeting CD3 T-Cell engager
Roche BP42169
TYRP
NCT04551352
An Open-Label, Multicenter, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7293583, A TYRP1-Targeting CD3 T-Cell Engager, in Participants With Metastatic Melanoma
Prof. Reinhard Dummer